CAI
CAI
NASDAQ · Biotechnology

Caris Life Sciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$16.15
-3.69 (-18.60%)
As of May 9, 1:16 AM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +91.5% upside
Low Target $20.23
Average Target $30.92
High Target $48.05
Current Price $16.15
Current
$16.15
Target
$30.92
$20.23 $30.92 avg $48.05
Scenario Analysis
Bear Case
$20.23
25.3%
Low target
Base Case
$30.92
+91.5%
Avg target
Bull Case
$48.05
+197.5%
High target
Risk/Reward
7.8x
Highly favorable
Price in Context
52-Week High
$42.50
-62.0% from high
52-Week Low
$16.28
+-0.8% from low
50-Day SMA
$25.57
-36.8% vs SMA
RSI (14)
21.6
Oversold
Target vs 52W High
$30.92
-27.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%